THOMAS FRANK E

Director at CRITICAL THERAPEUTICS INC · on record since Jun 27, 2006
Director at Larimar Therapeutics, Inc. · on record since May 20, 2026
VP, Finance & CFO at Esperion Therapeutics, Inc. · on record since Feb 9, 2004
President & COO at ADVANCED MAGNETICS INC · on record since Jun 8, 2015
CFO, SVP Finance and Treasurer at CRITICAL THERAPEUTICS INC · on record since Jan 25, 2005
Director at SmartPros Ltd. · on record since Nov 1, 2017
See Remarks at Protalix BioTherapeutics, Inc. · on record since Jan 6, 2020

Insider trading activity of THOMAS FRANK E

Transactions on record: 153; since Aug 28, 2003

Open-market buys: 9; $98.8K

Open-market sells: 12; $2.6M

Companies traded: 6; last filing Jun 25, 2026

Figures computed from official regulatory filings — methodology.

Companies where THOMAS FRANK E has traded

SmartPros Ltd.13 tx · $55K · Jun 25, 2026
Larimar Therapeutics, Inc.15 tx · $47K · May 20, 2026
Protalix BioTherapeutics, Inc.45 tx · $99.6K · Jan 24, 2024
ADVANCED MAGNETICS INC43 tx · $3.9M · Feb 27, 2017
CRITICAL THERAPEUTICS INC22 tx · $1.6M · Aug 22, 2007
Esperion Therapeutics, Inc.15 tx · Feb 12, 2004

Track record of THOMAS FRANK E

Statistical track record

Free

Open-market buys: 9

Last buy: Feb 27, 2026

Win rates and median returns are available with a free account (5 insiders/month).

Create a free account

Transaction history of THOMAS FRANK E

Co-insiders of THOMAS FRANK E

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

Company	Filed	Type	Qty	Price	Value · USD	Src
SmartPros Ltd.	Jun 25, 2026	Award	10,000	0.00 USD	—	SEC
SmartPros Ltd.	Jun 25, 2026	AwardD	20,000	0.00 USD	—	SEC
Larimar Therapeutics, Inc.	May 20, 2026	AwardD	55,150	0.00 USD	$0	SEC
Larimar Therapeutics, Inc.	Mar 2, 2026	Buy	5,000	5.00 USD	$25K	SEC
SmartPros Ltd.	Jun 16, 2025	Award	20,000	0.00 USD	$0	SEC
Larimar Therapeutics, Inc.	May 14, 2025	AwardD	19,000	0.00 USD	$0	SEC
Larimar Therapeutics, Inc.	May 31, 2024	AwardD	19,000	0.00 USD	$0	SEC
SmartPros Ltd.	May 30, 2024	Award	20,000	0.00 USD	$0	SEC
Larimar Therapeutics, Inc.	Feb 15, 2024	Buy	2,000	11.00 USD	$22K	SEC
Protalix BioTherapeutics, Inc.	Jan 24, 2024	OtherD	-457,800	0.00 USD	$0	SEC
Protalix BioTherapeutics, Inc.	Jan 24, 2024	OtherD	-75,000	0.00 USD	$0	SEC
Protalix BioTherapeutics, Inc.	Jan 24, 2024	OtherD	-335,000	0.00 USD	$0	SEC
Protalix BioTherapeutics, Inc.	Jan 24, 2024	OtherD	-309,990	0.00 USD	$0	SEC
Protalix BioTherapeutics, Inc.	Jan 24, 2024	OtherD	-27,730	0.00 USD	$0	SEC
Protalix BioTherapeutics, Inc.	Jan 24, 2024	OtherD	-199,990	0.00 USD	$0	SEC
Protalix BioTherapeutics, Inc.	Jan 24, 2024	OtherD	-149,990	0.00 USD	$0	SEC
Protalix BioTherapeutics, Inc.	Jan 24, 2024	OtherD	-179,390	0.00 USD	$0	SEC
Protalix BioTherapeutics, Inc.	Jan 24, 2024	OtherD	-99,980	0.00 USD	$0	SEC
Protalix BioTherapeutics, Inc.	Jan 24, 2024	OtherD	-405,590	0.00 USD	$0	SEC
Protalix BioTherapeutics, Inc.	Jan 24, 2024	Other	-92,081	—	—	SEC
SmartPros Ltd.	Oct 10, 2023	Award	20,000	0.00 USD	$0	SEC
Larimar Therapeutics, Inc.	May 11, 2023	AwardD	8,300	0.00 USD	$0	SEC
Protalix BioTherapeutics, Inc.	Mar 14, 2023	ExerciseD	-20,000	0.00 USD	$0	SEC
Protalix BioTherapeutics, Inc.	Mar 14, 2023	Exercise	20,000	0.46 USD	$9.2K	SEC
Protalix BioTherapeutics, Inc.	Mar 3, 2023	AwardD	405,600	0.00 USD	$0	SEC

Company	Filed	Type	Qty	Price	Value · USD	Src
SmartPros Ltd.	Jun 25, 2026	Award	10,000	0.00 USD	—	SEC
SmartPros Ltd.	Jun 25, 2026	AwardD	20,000	0.00 USD	—	SEC
Larimar Therapeutics, Inc.	May 20, 2026	AwardD	55,150	0.00 USD	$0	SEC
Larimar Therapeutics, Inc.	Mar 2, 2026	Buy	5,000	5.00 USD	$25K	SEC
SmartPros Ltd.	Jun 16, 2025	Award	20,000	0.00 USD	$0	SEC
Larimar Therapeutics, Inc.	May 14, 2025	AwardD	19,000	0.00 USD	$0	SEC
Larimar Therapeutics, Inc.	May 31, 2024	AwardD	19,000	0.00 USD	$0	SEC
SmartPros Ltd.	May 30, 2024	Award	20,000	0.00 USD	$0	SEC
Larimar Therapeutics, Inc.	Feb 15, 2024	Buy	2,000	11.00 USD	$22K	SEC
Protalix BioTherapeutics, Inc.	Jan 24, 2024	OtherD	-457,800	0.00 USD	$0	SEC
Protalix BioTherapeutics, Inc.	Jan 24, 2024	OtherD	-75,000	0.00 USD	$0	SEC
Protalix BioTherapeutics, Inc.	Jan 24, 2024	OtherD	-335,000	0.00 USD	$0	SEC
Protalix BioTherapeutics, Inc.	Jan 24, 2024	OtherD	-309,990	0.00 USD	$0	SEC
Protalix BioTherapeutics, Inc.	Jan 24, 2024	OtherD	-27,730	0.00 USD	$0	SEC
Protalix BioTherapeutics, Inc.	Jan 24, 2024	OtherD	-199,990	0.00 USD	$0	SEC
Protalix BioTherapeutics, Inc.	Jan 24, 2024	OtherD	-149,990	0.00 USD	$0	SEC
Protalix BioTherapeutics, Inc.	Jan 24, 2024	OtherD	-179,390	0.00 USD	$0	SEC
Protalix BioTherapeutics, Inc.	Jan 24, 2024	OtherD	-99,980	0.00 USD	$0	SEC
Protalix BioTherapeutics, Inc.	Jan 24, 2024	OtherD	-405,590	0.00 USD	$0	SEC
Protalix BioTherapeutics, Inc.	Jan 24, 2024	Other	-92,081	—	—	SEC
SmartPros Ltd.	Oct 10, 2023	Award	20,000	0.00 USD	$0	SEC
Larimar Therapeutics, Inc.	May 11, 2023	AwardD	8,300	0.00 USD	$0	SEC
Protalix BioTherapeutics, Inc.	Mar 14, 2023	ExerciseD	-20,000	0.00 USD	$0	SEC
Protalix BioTherapeutics, Inc.	Mar 14, 2023	Exercise	20,000	0.46 USD	$9.2K	SEC
Protalix BioTherapeutics, Inc.	Mar 3, 2023	AwardD	405,600	0.00 USD	$0	SEC